Marijn Vis

2.1k total citations
68 papers, 1.5k citations indexed

About

Marijn Vis is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Marijn Vis has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Rheumatology, 30 papers in Immunology and 18 papers in Hematology. Recurrent topics in Marijn Vis's work include Spondyloarthritis Studies and Treatments (43 papers), Rheumatoid Arthritis Research and Therapies (36 papers) and Psoriasis: Treatment and Pathogenesis (29 papers). Marijn Vis is often cited by papers focused on Spondyloarthritis Studies and Treatments (43 papers), Rheumatoid Arthritis Research and Therapies (36 papers) and Psoriasis: Treatment and Pathogenesis (29 papers). Marijn Vis collaborates with scholars based in Netherlands, United Kingdom and United States. Marijn Vis's co-authors include Willem F. Lems, Ben A. C. Dijkmans, Alexandre E. Voskuyl, Gertjan Wolbink, Michael T. Nurmohamed, Paul P. Tak, Els de Groot, Lucien A. Aarden, Steven O. Stapel and R J van de Stadt and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and Journal of Cellular Physiology.

In The Last Decade

Marijn Vis

59 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marijn Vis Netherlands 20 997 498 337 243 233 68 1.5k
William Shergy United States 19 1.2k 1.2× 561 1.1× 481 1.4× 228 0.9× 125 0.5× 24 1.9k
Serena Bugatti Italy 28 1.3k 1.3× 655 1.3× 301 0.9× 258 1.1× 87 0.4× 89 2.1k
Mark Cobby United Kingdom 15 836 0.8× 356 0.7× 405 1.2× 339 1.4× 123 0.5× 29 1.7k
Šárka Forejtová Czechia 15 1.0k 1.0× 401 0.8× 403 1.2× 212 0.9× 65 0.3× 32 1.4k
Herbert Kellner Germany 17 762 0.8× 523 1.1× 307 0.9× 137 0.6× 61 0.3× 38 1.2k
Julio Ramírez Spain 23 817 0.8× 633 1.3× 367 1.1× 254 1.0× 59 0.3× 82 1.3k
J.H.L.M. van Groenendael Netherlands 16 1.9k 1.9× 324 0.7× 744 2.2× 106 0.4× 101 0.4× 22 2.1k
Henrik Skjødt Denmark 20 647 0.6× 208 0.4× 187 0.6× 239 1.0× 102 0.4× 34 1.2k
P. Nicaise‐Roland France 24 931 0.9× 396 0.8× 262 0.8× 111 0.5× 43 0.2× 56 1.5k
Masao Nawata Japan 24 1.2k 1.2× 536 1.1× 344 1.0× 126 0.5× 47 0.2× 47 1.8k

Countries citing papers authored by Marijn Vis

Since Specialization
Citations

This map shows the geographic impact of Marijn Vis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijn Vis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijn Vis more than expected).

Fields of papers citing papers by Marijn Vis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijn Vis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijn Vis. The network helps show where Marijn Vis may publish in the future.

Co-authorship network of co-authors of Marijn Vis

This figure shows the co-authorship network connecting the top 25 collaborators of Marijn Vis. A scholar is included among the top collaborators of Marijn Vis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijn Vis. Marijn Vis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luime, Jolanda J., et al.. (2025). Psoriatic arthritis flare incidence, definition and risk factors: a systematic review. Lara D. Veeken. 64(9). 4886–4901.
3.
Helliwell, Philip, Marc R. Kok, Marijn Vis, et al.. (2024). The Development and Validation of a Novel Training Infographic for the Physician Global Visual Analog Scale in Psoriatic Arthritis. The Journal of Rheumatology. 51(11). 1084–1091.
4.
Mil, Annette H M van der Helm–van, Paco M J Welsing, Jolanda J. Luime, et al.. (2024). Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis. RMD Open. 10(4). e004687–e004687.
5.
Tillett, William, Laura C. Coates, Marijn Vis, et al.. (2023). POS1535 EARLY IMPROVEMENT IN 3VAS/4VAS PREDICTS REDUCED RATES OF RADIOGRAPHIC CHANGE IN BIO-NAIVE ACTIVE PSORIATIC ARTHRITIS PATIENTS RECEIVING GUSELKUMAB TREATMENT. Annals of the Rheumatic Diseases. 82. 1131–1132. 2 indexed citations
6.
Kok, Marc R., Jolanda J. Luime, Ilja Tchetverikov, et al.. (2023). Construct validity and responsiveness of feasible composite disease activity measures for use in daily clinical practice in patients with psoriatic arthritis. RMD Open. 9(4). e002972–e002972. 4 indexed citations
7.
Jong, Pascal H P de, et al.. (2022). OP0028 EARLY ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY IN PSORIATIC ARTHRITIS IS ASSOCIATED WITH LONG-TERM IMPROVEMENTS IN QUALITY OF LIFE. Annals of the Rheumatic Diseases. 81. 21–21. 1 indexed citations
8.
Lennep, Jeanine E. Roeters van, Martijn B. A. van Doorn, Marijn Vis, et al.. (2022). Prevalence of ideal cardiovascular health and its correlates in patients with inflammatory bowel disease, psoriasis and spondyloarthropathy. European Journal of Preventive Cardiology. 29(13). e314–e318. 5 indexed citations
9.
Pasma, Annelieke, Jolanda J. Luime, Ilja Tchetverikov, et al.. (2022). A Practical Guide for Assessment of Skin Burden in Patients With Psoriatic Arthritis. The Journal of Rheumatology. 49(10). 1117–1123. 1 indexed citations
11.
Straalen, Kelsey R. van, et al.. (2020). High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa. British Journal of Dermatology. 183(4). 763–765. 3 indexed citations
13.
Luime, Jolanda J., Ilja Tchetverikov, Andreas Gerards, et al.. (2019). Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis. Arthritis Research & Therapy. 21(1). 25–25. 12 indexed citations
14.
Both, Tim, M. Carola Zillikens, Marijke Schreuders‐Koedam, et al.. (2017). Hydroxychloroquine affects bone resorption both in vitro and in vivo. Journal of Cellular Physiology. 233(2). 1424–1433. 27 indexed citations
15.
Weel, A., Myrthe van der Ven, Marijn Vis, et al.. (2016). Performance of screening tools for psoriatic arthritis: a cross-sectional study in primary care. Lara D. Veeken. 56(4). kew410–kew410. 28 indexed citations
16.
Bultink, Irene E. M., Marijn Vis, Irene E. van der Horst‐Bruinsma, & Willem F. Lems. (2012). Inflammatory Rheumatic Disorders and Bone. Current Rheumatology Reports. 14(3). 224–230. 69 indexed citations
17.
Willems, Hanna C., Marijn Vis, Barbara C. Van Munster, et al.. (2012). Why do geriatric outpatients have so many moderate and severe vertebral fractures? Exploring prevalence and risk factors. Age and Ageing. 41(2). 200–206. 19 indexed citations
18.
Vis, Marijn, Espen A. Haavardsholm, Pernille Bøyesen, et al.. (2011). High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporosis International. 22(9). 2413–2419. 53 indexed citations
19.
Bos, Wouter H, G. M. Bartelds, Marijn Vis, et al.. (2008). Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 68(4). 558–563. 24 indexed citations
20.
Peters, Matthew, Marijn Vis, Vokko P. van Halm, et al.. (2007). Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(7). 958–961. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026